moclobemide has been researched along with maprotiline in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.11) | 18.7374 |
| 1990's | 11 (61.11) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 2 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Allain, H; Brunet-Bourgin, F; Gandon, JM; Le Coz, F; Lieury, A; Mirabaud, C; Trebon, P | 1 |
| Laux, G; Lesch, KP; Mueller, T | 1 |
| Classen, W; Laux, G | 1 |
| Agnoli, A; Anand, R; De Vanna, M; Gentili, P; Kummer, J; Lorizio, A | 1 |
| Classen, W | 1 |
| Becker, T; Beckmann, H; Classen, W; Laux, G | 1 |
| Blier, P; De Montigny, C; Mongeau, R | 1 |
| Dick, P; Gachoud, JP; Köhler, M | 1 |
| Albuquerque, AJ; Figueira, ML; Firmino, H; Jara, JM; Pestana, LC; Vaz-Serra, A | 1 |
| Arnoldt, KH; Steinmeyer, EM; Vorbach, EU | 1 |
| Bech, P | 1 |
| Angst, J; Delini-Stula, A; Mikkelsen, H | 1 |
| Hauger, B; König, F; Löble, M; Wolfersdorf, M; Wössner, S | 1 |
| Koval'chuk, VV | 1 |
2 review(s) available for moclobemide and maprotiline
| Article | Year |
|---|---|
Acute therapy of depression.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzamides; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Humans; Maprotiline; Meta-Analysis as Topic; Moclobemide; Monoamine Oxidase Inhibitors; Nomifensine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index | 1993 |
Therapeutic efficacy of antidepressants in agitated anxious depression--a meta-analysis of moclobemide studies.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents; Anxiety Disorders; Benzamides; Clinical Trials as Topic; Depressive Disorder; Female; Humans; Imipramine; Male; Maprotiline; Mianserin; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Personality Assessment; Psychomotor Agitation; Treatment Outcome | 1995 |
9 trial(s) available for moclobemide and maprotiline
| Article | Year |
|---|---|
Antidepressants and cognition: comparative effects of moclobemide, viloxazine and maprotiline.
Topics: Adult; Antidepressive Agents; Arousal; Attention; Benzamides; Cognition; Depression; Double-Blind Method; Female; Humans; Male; Maprotiline; Memory; Moclobemide; Monoamine Oxidase Inhibitors; Multicenter Studies as Topic; Psychiatric Status Rating Scales; Viloxazine | 1992 |
Psychometric alterations in treatment with the MAO-A-inhibitor moclobemide.
Topics: Benzamides; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Maprotiline; Middle Aged; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Psychiatric Status Rating Scales; Psychometrics; Psychomotor Performance | 1990 |
Moclobemide compared with second-generation antidepressants in elderly people.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Benzamides; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Maprotiline; Mianserin; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Psychiatric Status Rating Scales | 1990 |
Moclobemide and maprotiline in the treatment of inpatients with major depressive disorder.
Topics: Anthracenes; Benzamides; Blood Pressure; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Maprotiline; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Psychiatric Status Rating Scales; Random Allocation | 1989 |
Comparison of the efficacy and tolerability of moclobemide and maprotiline in depressed patients treated by general practitioners.
Topics: Antidepressive Agents; Benzamides; Depressive Disorder; Double-Blind Method; Family Practice; Female; Humans; Male; Maprotiline; Middle Aged; Moclobemide; Psychiatric Status Rating Scales | 1994 |
Multicenter double-blind study of moclobemide and maprotiline.
Topics: Adult; Antidepressive Agents; Benzamides; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Maprotiline; Middle Aged; Moclobemide; Psychiatric Status Rating Scales | 1994 |
Efficacy and safety of moclobemide compared with maprotiline in treatment of major depressive disorder. A double-blind multicenter study with parallel groups.
Topics: Adolescent; Adult; Aged; Benzamides; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Maprotiline; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Prospective Studies; Psychiatric Status Rating Scales | 1993 |
Trimipramine and maprotiline plasma levels during combined treatment with moclobemide in therapy-resistant depression.
Topics: Adult; Aged; Antidepressive Agents; Benzamides; Depressive Disorder; Drug Interactions; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Maprotiline; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Trimipramine | 1997 |
[Pharmacologic correction of psycho-emotive disorders in the rehabilitation of patients after removal of brain tumors].
Topics: Adult; Alprazolam; Amitriptyline; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Brain Neoplasms; Depression; Doxepin; Emotions; Female; Humans; Male; Maprotiline; Middle Aged; Moclobemide; Mood Disorders; Neurosurgical Procedures; Nialamide; Sertraline; Thiazepines; Trazodone; Treatment Outcome | 2007 |
7 other study(ies) available for moclobemide and maprotiline
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Alpha 2-adrenoceptor responsivity in depression: effect of chronic treatment with moclobemide, a selective MAO-A-inhibitor, versus maprotiline.
Topics: Adult; Benzamides; Clonidine; Depressive Disorder; Female; Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Maprotiline; Middle Aged; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Psychiatric Status Rating Scales; Receptors, Adrenergic, alpha | 1990 |
[Psychometric findings in treatment using the selective MAO-A inhibitors moclobemide and maprotiline].
Topics: Adult; Anthracenes; Antidepressive Agents; Arousal; Benzamides; Depressive Disorder; Female; Humans; Male; Maprotiline; Middle Aged; Moclobemide; Motivation; Psychiatric Status Rating Scales; Psychomotor Performance; Reaction Time | 1989 |
Effect of long-term administration of antidepressant drugs on the 5-HT3 receptors that enhance the electrically evoked release of [3H]noradrenaline in the rat hippocampus.
Topics: Animals; Antidepressive Agents; Benzamides; Desipramine; Electric Stimulation; Fluoxetine; Hippocampus; In Vitro Techniques; Male; Maprotiline; Moclobemide; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Trimipramine | 1994 |